|Articles|May 23, 2022
Supplements and Featured Publications
- Clinical Trial Data Can Be Supplemented by Real-World Evidence: An Example for an Oral Anticoagulant in Patients With Nonvalvular Atrial Fibrillation at Risk of Stroke
Clinical Trial Data Can Be Supplemented by Real-World Evidence: An Example for an Oral Anticoagulant in Patients With Nonvalvular Atrial Fibrillation at Risk of Stroke
Advertisement
This article presents an example of how clinical trial data may be complemented by real-world evidence by reviewing pivotal clinical trial data for one direct oral anticoagulant (DOAC), along with an observational retrospective real-world database analysis that evaluated the effectiveness and safety of that DOAC in the real world.
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
ATTR-CM Incidence, Prevalence Rose Sharply in the US
2
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
3
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
4
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
5